Folate transporter offers clues for anticancer drugs.
Where this comes from
- Record sourced from PubMed, PMID 36418878.
- Also identified by DOI 10.1038/d41586-022-03767-5 and PMC identifier PMC9990147.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Structural insights into a long-studied folate-transport protein provide evidence that might lead to entirely new targeted anticancer treatments, or boost the success of immunotherapy approaches to tackling tumours.